Brief: Zeria Pharmaceutical gets manufacture and marketing approval for Zentacort Capsules 3mg

Zeria Pharmaceutical

28/09/2016 07:28

Sept 28 (Reuters) - Zeria Pharmaceutical Co Ltd  4559.T  : 
     
    * Says it gets manufacture and marketing approval for 
Zentacort Capsules 3mg (Budesonide), as treatment for Crohn's 
disease 
 
    Source text in Japanese: https://goo.gl/gwE1Ln 
    Further company coverage: 4559.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))